Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩3,965 (-0.13%) as of
Key statistics
- Market cap
- 91.88B
- Dividend yield
- 0.00%
- 52-week range
- 3,350.00 – 11,520.00
- Profit margin
- 0.00%
- Volume
- 44.47k
About Vaxcell-Bio Therapeutics Co., Ltd.
Vaxcell-Bio Therapeutics Co., Ltd. develops and anticancer immunotherapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Hwasun-eup, South Korea
- Employees
- 58
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.